Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review

References

• World Health Organization. Antimicrobial resistance: draft global action plan on antimicrobial resistance. Sixty-Eighth World Health Assembly A68/20. 2015 [cited 2016 Apr 28]. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_20-en.pdf
   Google Scholar
• Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.
   PubMed Web of Science ®Google Scholar
• Drekonja DM, Filice GA, Greer N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol. 2015;36(2):142–152.
   PubMed Web of Science ®Google Scholar
• Chapman AL, Seaton RA, Cooper MA, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053–1062.
   PubMed Web of Science ®Google Scholar
• Chapman AL. Outpatient parenteral antimicrobial therapy in a changing NHS: challenges and opportunities. Clin Med. 2013;13(1):35–36.
   PubMed Web of Science ®Google Scholar
• Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38:1651–1672.
   PubMed Web of Science ®Google Scholar
• MacKenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents. 2014;43:7–16.
   PubMed Web of Science ®Google Scholar
• The British Society for Antimicrobial Chemotherapy. National outcomes registry (NORS). OPAT Registry. User guide for NORS (Adult & Paediatric). [cited 2017 Feb 21]. Available from: http://opatregistry.com/documents/userguide.pdf
   Google Scholar
• Goodfellow AF, Wai AO, Frighetto L, et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother. 2002;36(12):1851–1855.
   PubMed Web of Science ®Google Scholar
• Palmer S, Raftery J. Opportunity cost. Bmj. 1999;318(7197):1551–1552.
   PubMed Web of Science ®Google Scholar
• Russell LB, Siegel JE, Daniels N, et al. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. Oxford: Oxford University Press; 1996. p. 3–24.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269.
   PubMed Web of Science ®Google Scholar
• Van Mastrigt GA, Hiligsmann M, Arts JJ, et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16(6):689–704.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.
   Google Scholar
• Fundação de amparo à pesquisa do estado de São Paulo - FAPESP. Processo 14/50045-3. Terapia antimicrobiana parenteral ambulatorial baseada em hospital-dia, como ferramenta custo-efetiva de desospitalização no Sistema Único de Saúde. [cited 2017 Jan 17]. Available from: http://www.bv.fapesp.br/pt/auxilios/86784/terapia-antimicrobiana-parenteral-ambulatorial-baseada-em-hospital-dia-como-ferramenta-custo-efetiv/
   Google Scholar
• Ruh CA, Parameswaran GI, Wojciechowski AL, et al. Outcomes and pharmacoeconomic analysis of a home intravenous antibiotic infusion program in veterans. ‎Clin Ther. 2015;37(11):2527–2535.
   PubMed Web of Science ®Google Scholar
• Malone M, West D, Xuan W, et al. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes. Diabetes Metab Res Rev. 2015;31:638–645.
   PubMed Web of Science ®Google Scholar
• Subedi S, Looke DFM, McDougall DA, et al. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis. 2015;30:161–165.
   PubMed Web of Science ®Google Scholar
• Ektare V, Khachatryan A, Xue M, et al. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting. J Med Econ. 2015;18(12):1092–1101.
   PubMed Web of Science ®Google Scholar
• Beieler AM, Dellit TH, Chan JD, et al. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients. J Hosp Med. 2016;11(8):531–535.
   PubMed Web of Science ®Google Scholar
• Peña MRF, Amores AIP, Lucena ED, et al. Análisis coste-eficacia de un programa de tratamiento antimicrobiano parenteral ambulatorio de base hospitalaria. [Cost-effectiveness analysis of the outpatient parenteral antimicrobial therapy program with ambulatory hospital basis]. Enfermería Docente. 2016;1(106): 94–95. Spanish.
   Google Scholar
• Hernandez W, Price C, Knepper B, et al. Oral parenteral antimicrobial therapy administration in a homeless population. J Infus Nurs. 2016;39(2):81–85.
   PubMed Web of Science ®Google Scholar
• Kameshwar K, Karahalios A, Janus E, et al. False economies in home-based parenteral antibiotic treatment: a health-economic case study of management of lower-limb cellulitis in Australia. J Antimicrob Chemother. 2016;71:830–835.
   PubMed Web of Science ®Google Scholar
• Antoniskis A, Anderson BC, Van Volkinburg EJ, et al. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med. 1978 Mar;128(3):203–206.
   PubMedGoogle Scholar
• Stiver HG, Trosky SK, Cote DD, et al. Self-administration of intravenous antibiotics: an efficient, cost-effective home care program. Can Med Assoc J. 1982;127(3):207–211.
   PubMed Web of Science ®Google Scholar
• Eisenberg JM, Kitz DS. Savings from outpatient antibiotic therapy for osteomyelitis. Economic analysis of a therapeutic strategy. Jama. 1986;255(12):1584–1588.
   PubMed Web of Science ®Google Scholar
• Chamberlain TM, Lehman ME, Groh MJ, et al. Cost analysis of a home intravenous antibiotic program. Am J Hosp Pharm. 1988;45(11):2341–2345.
   PubMedGoogle Scholar
• Hindes R, Winkler C, Kane P, et al. Outpatient intravenous antibiotic therapy in medicare patients: cost-savings analysis. Infect Dis Clin Pract (Baltim Md). 1995;4(3):211–217.
   Web of Science ®Google Scholar
• Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care. Med J Aust. 1995;162(5):249–253.
   PubMed Web of Science ®Google Scholar
• Graf Von Der Schulenburg JM, Greiner W, Klettke U, et al. Ökonomische Aspekte der Behandlung zystischer Fibrose mit chronischer pulmonaler Pseudomonasinfektion. [Economic aspects in treatment of cystic fibrosis with chronic pulmonary pseudomonas infection. Ambulatory intravenous therapy in comparison with inpatient treatment]. Med Klin(Munich). 1997;92(10): 626–629. German.
   PubMedGoogle Scholar
• Nathwani D, Morrison J, Seaton RA, et al. Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year’s experience in Tayside. Health Bull (Edinb). 1999;57(5):332–337.
   PubMedGoogle Scholar
• Wai AO, Frighetto L, Marra CA, et al. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme: a Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics. 2000;18(5):451–457.
   PubMed Web of Science ®Google Scholar
• Dalovisio JR, Juneau J, Baumgarten K, et al. Financial impact of a home intravenous antibiotic program on a medicare managed care program. Clin Infect Dis. 2000;30(4):639–642.
   PubMed Web of Science ®Google Scholar
• Steinmetz D, Berkovits E, Edelstein H, et al. Home intravenous antibiotic therapy programme, 1999. J Infect. 2001;42(3):176–180.
   PubMed Web of Science ®Google Scholar
• Bernard L, El-Hajj PB, Lotthé A, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther. 2001;26(6):445–451.
   PubMed Web of Science ®Google Scholar
• Wolter JM, Cagney RA, McCormack JG. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. J Infect. 2004;48(3):263–268.
   PubMed Web of Science ®Google Scholar
• Fisher DA, Kurup A, Lye D, et al. Outpatient parenteral antibiotic therapy in Singapore. Int J Antimicrob Agents. 2006;28(6):545–550.
   PubMed Web of Science ®Google Scholar
• Chapman AL, Dixon S, Andrews D, et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64(6):1316–1324.
   PubMed Web of Science ®Google Scholar
• Yong C, Fisher DA, Sklar GE, et al. A cost analysis of outpatient parenteral antibiotic therapy (OPAT): an Asian perspective. Int J Antimicrob Agents. 2009;33(1):46–51.
   PubMed Web of Science ®Google Scholar
• Kieran J, O’Reilly A, Parker J, et al. Self-administered outpatient parenteral antimicrobial therapy: a report of three years’ experience in the Irish healthcare setting. Eur J Clin Microbiol Infect Dis. 2009;28(11):1369–1374.
   PubMed Web of Science ®Google Scholar
• Teuffel O, Amir E, Alibhai S, et al. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. Br J Cancer. 2011;104(9):1377–1383.
   PubMed Web of Science ®Google Scholar
• Heintz BH, Halilovic J, Christensen CL. Impact of a multidisciplinary team review of potential outpatient parenteral Antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother. 2011;45:1329–1337.
   PubMed Web of Science ®Google Scholar
• Theocharis G, Rafailidis PI, Rodis D, et al. Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece. Eur J Clin Microbiol Infect Dis. 2012;31(11):2957–2961.
   PubMed Web of Science ®Google Scholar
• Semple L. Outpatient antimicrobial therapy (OPAT), NHS greater Glasgow and Clyde: economic case study – year 2011-2012. 2012 [cited 2017 Feb 22]. [14 p.]. Available from: https://www.rcn.org.uk/professional-development/research-and-innovation/innovation-in-nursing/building-nursing-capability-in-economic-assessment/lindsay-semple
   Google Scholar
• Al Ansari A, Al Alawi S, Al Qahtani M, et al. Outpatient parenteral antimicrobial therapy (OPAT) in the Kingdom of Bahrain. Toidj. 2013;7:90–95.
   Google Scholar
• Lai A, Tran T, Nguyen HM, et al. Outpatient parenteral antimicrobial therapy at large veteran administration medical center. Am J Manag Care. 2013;19(9):e317–24.
   PubMed Web of Science ®Google Scholar
• Sims AL, Baker P, Bellamy R, et al. Outpatient parenteral antibiotic therapy in primary hip and knee arthroplasty infection managed with debridement and retention of prosthesis: a retrospective cohort study. Surg Infect (Larchmt). 2013;14(3):293–296.
   PubMed Web of Science ®Google Scholar
• Lacroix A, Revest M, Patrat-Delon S, et al. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy. Med Mal Infect. 2014;44(7):327–330.
   PubMed Web of Science ®Google Scholar
• Revankar N, Ward AJ, Pelligra CG, et al. Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections. J Med Econ. 2014;17(10):730–740.
   PubMedGoogle Scholar
• Seaton RA, Johal S, Coia JE, et al. Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals. Eur J Clin Microbiol Infect Dis. 2014;33(3):305–311.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO global health expenditure atlas. Switzerland: World Health Organization; 2014 [cited 2016 Jul 18]. Available from: http://www.who.int/health-accounts/atlas2014.pdf
   Google Scholar
• Balinsky W, Nesbitt S. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature. Am J Med. 1989;87(3):301–305.
   PubMed Web of Science ®Google Scholar
• Welte R, Feenstra T, Jager H, et al. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics. 2004;22(13):857–876.
   PubMed Web of Science ®Google Scholar
• Galvão TF, Silva EN, Silva MT, et al. Economic evaluation of poison centers: a systematic review. Int J Technol Assess Health Care. 2012;28(2):86–92.
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–55.
   PubMed Web of Science ®Google Scholar
• Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists. J Antimicrob Chemother. 2015;70(4):965–970.
   PubMed Web of Science ®Google Scholar
• Esposito S, Noviello S, Leone S, et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004;24(5):473–478.
   PubMed Web of Science ®Google Scholar
• Williams DN, Baker CA, Kind AC, et al. The history and evolution of outpatient parenteral antibiotic therapy (OPAT). Int J Antimicrob Agents. 2015;46(3):307–312.
   PubMed Web of Science ®Google Scholar
• Guyatt G, Rennie D, Meade MO, et al. Users’ guides to the medical literature: a manual for evidence-based clinical practice. 3rd ed. New York: Mc Graw Hill; 2015.
   Google Scholar
• Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43(7):5–14.
   PubMed Web of Science ®Google Scholar
• Bilcke J, Beutels P, Brisson M, et al. Accounting for methodological, structural and parameter uncertainty in decision-analitic models: a practical guide. Med Decis Making. 2011;31(4):675–692.
   PubMed Web of Science ®Google Scholar
• Pérez Velasco R, Praditsitthikorn N, Wichmann K, et al. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One. 2012;7(2):e30333.
   PubMed Web of Science ®Google Scholar
• Silva EN, Silva MT, Pereira MG. Uncertainty in economic evaluation studies. Epidemiol Serv Saude. 2017;26(1):211–213.
   PubMed Web of Science ®Google Scholar
• Conant MM, Erdman SM, Osterholzer D. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. J Antimicrob Chemother. 2014;69(6):1695–1700.
   PubMed Web of Science ®Google Scholar